Source: Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Holly R. Keir, Alison Dicker, Mike Lonergan, Megan Crichton, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers. Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD. Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotypes of exacerbation are associated with differences in microbial composition and diversity in COPD Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Clinical phenotypic differences between COPD and asthma in elderly patients Source: Eur Respir J 2004; 24: Suppl. 48, 60s Year: 2004 Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002 Relationship between the respiratory microbiome and systemic patterns in COPD Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Azurocidin-1: a marker of COPD severity and microbial dysbiosis Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic. Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics Year: 2017 Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Asthma and COPD: similarities and differences in pathogenesis Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Severity-related microbiome changes in COPD Source: Annual Congress 2013 –COPD and infections Year: 2013 A study of the relation of microbiological etiology with analytical and clinical parameters in exacerbation of COPD Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Different pattern of systemic and local inflammation in patients with exacerbation of COPD with different body composition Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Similarities and differences in inflammatory mechanisms of asthma and COPD Source: Breathe 2011; 7: 229-238 Year: 2011 Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD Year: 2011 Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Sources of origin of the oropharyngeal microbiota in patients with different phenotypes of COPD Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Differences of clinical characteristics and phenotype between biomass and tobacco related COPD Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019